Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 4 (2007), Issue 9 (September)

1. Changing incidence of psychotic disorders among the young in Zurich.
   Schizophr Res, 95(1): 9-18. [Abstract] [Full-text]
2. Chasing the dragon in the ear.
   J Laryngol Otol, 121(9): e15. [Abstract] [Full-text]
3. Socioemotional effects of fathers' incarceration on low-income, urban, school-aged children.
   Pediatrics, 120(3): e678-85. [Abstract] [Full-text]
4. Recommendations for toxicological investigation of drug impaired driving.
   J Forensic Sci, 52(5): 1214-8. [Abstract] [Full-text]
5. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells.
   J Cell Physiol. [Abstract] [Full-text]
6. Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.
   J Neurosci, 27(36): 9537-44. [Abstract] [Full-text]
7. A comparative study of obsessive-compulsive disorder in Costa Rica and the United States.
   Depress Anxiety. [Abstract] [Full-text]
8. Organelle DNA haplotypes reflect crop-use characteristics and geographic origins of Cannabis sativa.
   Forensic Sci Int, 172(2): 179-90. [Abstract] [Full-text]
9. Substance use risk behaviors and decision-making skills among cancer-surviving adolescents.
   J Pediatr Oncol Nurs, 24(5): 264-73. [Abstract] [Full-text]
10. Marijuana use and sexually transmitted infections in young women who were teenage mothers.
    Womens Health Issues, 17(5): 300-9. [Abstract] [Full-text]
11. The discovery of Capparis spinosa L. (Capparidaceae) in the Yanghai Tombs (2800 years b.p.), NW China, and its medicinal implications.
    J Ethnopharmacol, 113(3): 409-20. [Abstract] [Full-text]
12. Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia.
    Aust N Z J Psychiatry, 41(10): 792-9. [Abstract] [Full-text]
13. Differential Sensitivity of GABAA Receptor-Mediated IPSCs to Cannabinoids in Hippocampal Slices From Adolescent and Adult Rats.
    J Neurophysiol, 98(3): 1223-30. [Abstract] [Full-text]
14. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.
    Psychopharmacology (Berl), 194(3): 371-9. [Abstract] [Full-text]
15. Suicide risk and protective factors among youth experiencing school difficulties.
    Int J Ment Health Nurs, 16(5): 349-59. [Abstract] [Full-text]
16. Marijuana coping motives interact with marijuana use frequency to predict anxious arousal, panic related catastrophic thinking, and worry among current marijuana users.
    Depress Anxiety. [Abstract] [Full-text]
17. Tobacco, alcohol, and illicit drug use in adolescents with diabetes mellitus.
    Pediatr Diabetes, 8(5): 265-71. [Abstract] [Full-text]
18. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
    Int J Drug Policy, 18(5): 374-80. [Abstract] [Full-text]
19. Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia.
    Neuropsychopharmacology, 32(10): 2067-73. [Abstract] [Full-text]
20. Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA).
    Drug Alcohol Depend, 91(1): 85-90. [Abstract] [Full-text]
21. A descriptive epidemiology of substance use and substance use disorders in Nigeria during the early 21st century.
    Drug Alcohol Depend, 91(1): 1-9. [Abstract] [Full-text]
22. The latent structure of marijuana and cocaine use disorders: results from the National Longitudinal Alcohol Epidemiologic Survey (NLAES).
    Drug Alcohol Depend, 91(1): 91-6. [Abstract] [Full-text]
23. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and triangle up9-THC.
    Eur J Pharmacol, 572(1): 32-9. [Abstract] [Full-text]
24. Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances.
    Expert Rev Neurother, 7(9): 1157-63. [Abstract] [Full-text]
25. Driving after use of alcohol and marijuana in college students.
    Psychol Addict Behav, 21(3): 425-30. [Abstract] [Full-text]
26. Moderating effects of sensitivity to punishment and sensitivity to reward on associations between marijuana effect expectancies and use.
    Psychol Addict Behav, 21(3): 409-14. [Abstract] [Full-text]
27. Everyday memory deficits in ecstasy-polydrug users.
    J Psychopharmacol, 21(7): 709-17. [Abstract] [Full-text]
28. Functional MRI of inhibitory processing in abstinent adolescent marijuana users.
    Psychopharmacology (Berl), 194(2): 173-83. [Abstract] [Full-text]
29. Treatment of cannabis use disorders: a review of the literature.
    Am J Addict, 16(5): 331-42. [Abstract] [Full-text]
30. Doping prevalence among preadolescent athletes: a 4-year follow-up.
    Br J Sports Med, 41(10): 660-3; discussion 663. [Abstract] [Full-text]
31. Cannabis; adverse effects from an oromucosal spray.
    Br Dent J, 203(6): E12; discussion 336-7. [Abstract] [Full-text]
32. Adverse effects from a cannabis spray.
    Br Dent J, 203(6): 336-7. [Abstract] [Full-text]
33. The Future of Cannabinoids as Analgesic Agents: A Pharmacologic, Pharmacokinetic, and Pharmacodynamic Overview.
    Am J Ther, 14(5): 475-483. [Abstract] [Full-text]
34. Management of larynx and trachea donors.
    Transplant Proc, 39(7): 2076-8. [Abstract] [Full-text]
35. Prevalence and correlates of substance use among high school students in South Africa and the United States.
    Am J Public Health, 97(10): 1859-64. [Abstract] [Full-text]
36. Prospective memory impairment in "ecstasy" (MDMA) users.
    Psychopharmacology (Berl), 194(4): 497-504. [Abstract] [Full-text]
37. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users.
    Psychopharmacology (Berl), 194(4): 505-15. [Abstract] [Full-text]
38. Exposure to terrorism and Israeli youths' cigarette, alcohol, and cannabis use.
    Am J Public Health, 97(10): 1852-8. [Abstract] [Full-text]
39. The effect of migration to the United States on substance use disorders among returned Mexican migrants and families of migrants.
    Am J Public Health, 97(10): 1847-51. [Abstract] [Full-text]
40. Functional imaging studies in cannabis users.
    Neuroscientist, 13(5): 422-32. [Abstract] [Full-text]

© 2004-2008 Marijuana Research Today. All Rights Reserved.